BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
panacea biotec ltd stock

PANACEA BIOTEC LTD Share Price

471 5.54 (1.19%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: PANACEABIO

PANACEA BIOTEC LTD Share Price Update

As of the latest trading session, PANACEA BIOTEC LTD share price is currently at 471, which is up by 5.54 from its previous closing. Today, the stock has fluctuated between 451.00 and 475.85. Over the past year, PANACEA BIOTEC LTD has achieved a return of 180.43 %. In the last month alone, the return has been 37.12 %. Read More...

PANACEA BIOTEC LTD Performance

Day Range

Low451.00 High475.85
467.20

52 Week Range

Low 112.35 High 487.00
467.20

PANACEA BIOTEC LTD Share Price

8728

531349

PANACEABIO

img img img img
No Data Available

Open Price

465.45

Prev. Close

465.45

Volume (Shares)

48968.00

Total traded value

228.77

Upper Circuit

488.70

Lower Circuit

442.20

Note: The current prices & values are delayed, Login to your account for live updates.

PANACEA BIOTEC LTD Fundamentals


(Standalone)

Market Cap (Cr) 2884.91
PE Ratio (TTM) -212.63
Book Value / Share 51.69
Beta 0.83
ROE 0.86%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.29

PANACEA BIOTEC LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 76.64
Operating Expense 78.75
Net Profit 1.29
Net Profit Margin (%) 1.68
Earnings Per Share (EPS) 0.21
EBITDA 10.14
Effective Tax Rate (%) 0.76
Particulars JUN 2024 (Values in Cr)
Revenue 56.88
Operating Expense 75.66
Net Profit -13.78
Net Profit Margin (%) -24.22
Earnings Per Share (EPS) -2.25
EBITDA -6.68
Effective Tax Rate (%) 8.01
Particulars MAR 2024 (Values in Cr)
Revenue 80.37
Operating Expense 98.11
Net Profit -1.37
Net Profit Margin (%) -1.70
Earnings Per Share (EPS) -0.22
EBITDA 7.14
Effective Tax Rate (%) -1.48
Particulars DEC 2023 (Values in Cr)
Revenue 95.23
Operating Expense 97.21
Net Profit 0.43
Net Profit Margin (%) 0.45
Earnings Per Share (EPS) 0.07
EBITDA 9.69
Effective Tax Rate (%) 59.81
Particulars SEP 2023 (Values in Cr)
Revenue 94.59
Operating Expense 93.52
Net Profit 3.20
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 0.52
EBITDA 12.09
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 359.60
Operating Expense 380.29
Net Profit 3.55
Net Profit Margin (%) 0.98
Earnings Per Share (EPS) 0.58
EBITDA 39.08
Effective Tax Rate (%) 15.67
Particulars MAR 2023 (Values in Cr)
Revenue 257.07
Operating Expense 354.25
Net Profit -87.54
Net Profit Margin (%) -34.05
Earnings Per Share (EPS) -14.29
EBITDA -28.18
Effective Tax Rate (%) -39.50
Particulars MAR 2022 (Values in Cr)
Revenue 235.50
Operating Expense 341.65
Net Profit -93.58
Net Profit Margin (%) -39.73
Earnings Per Share (EPS) -15.28
EBITDA -60.10
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 343.56
Operating Expense 377.15
Net Profit -14.44
Net Profit Margin (%) -4.20
Earnings Per Share (EPS) -2.35
EBITDA 21.24
Effective Tax Rate (%) -12.14
Particulars MAR 2020 (Values in Cr)
Revenue 158.09
Operating Expense 252.49
Net Profit -153.08
Net Profit Margin (%) -96.83
Earnings Per Share (EPS) -24.99
EBITDA -46.75
Effective Tax Rate (%) -21.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 133.94
ROE % -4.07
ROCE % -3.34
Total Debt to Total Equity 0.02
EBITDA Margin 1.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 134.20
ROE % -11.06
ROCE % -9.50
Total Debt to Total Equity 0.03
EBITDA Margin -11.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 139.59
ROE % -60.80
ROCE % -5.11
Total Debt to Total Equity 1.32
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share -40.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 13.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 23.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.53
EBITDA Margin 15.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 50.20
ROE % 0.86
ROCE % 3.26
Total Debt to Total Equity 0.32
EBITDA Margin 10.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.63
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin -10.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin -25.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.43
ROE % -2.53
ROCE % -1.10
Total Debt to Total Equity 0.09
EBITDA Margin 5.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share 136.97
ROE % -18.56
ROCE % -8.22
Total Debt to Total Equity 0.58
EBITDA Margin -37.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 139.48
Total Assets 1240.67
Total Liabilities 1240.67
Total Equity 838.22
Share Outstanding 61250746
Price to Book Ratio 2.42
Return on Assets (%) -0.09
Return on Capital (%) -0.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 225.99
Total Assets 1271.16
Total Liabilities 1271.16
Total Equity 840.11
Share Outstanding 61250746
Price to Book Ratio 2.18
Return on Assets (%) -2.61
Return on Capital (%) -3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 583.27
Total Assets 1758.86
Total Liabilities 1758.86
Total Equity 873.65
Share Outstanding 61250746
Price to Book Ratio 2.31
Return on Assets (%) 61.30
Return on Capital (%) 118.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 135.79
Total Assets 1177.53
Total Liabilities 1177.53
Total Equity -231.69
Share Outstanding 61250750
Price to Book Ratio 2.23
Return on Assets (%) -12.54
Return on Capital (%) -25.13
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 89.75
Total Assets 1390.30
Total Liabilities 1390.30
Total Equity 195.74
Share Outstanding 61250750
Price to Book Ratio 0.80
Return on Assets (%) -13.97
Return on Capital (%) -23.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 29.43
Total Assets 753.64
Total Liabilities 753.64
Total Equity 329.14
Share Outstanding 61250746
Price to Book Ratio 2.42
Return on Assets (%) 0.47
Return on Capital (%) 0.78
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 43.25
Total Assets 723.90
Total Liabilities 723.90
Total Equity 325.65
Share Outstanding 61250746
Price to Book Ratio 2.18
Return on Assets (%) -12.09
Return on Capital (%) -20.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 42.68
Total Assets 761.83
Total Liabilities 761.83
Total Equity 415.09
Share Outstanding 61250746
Price to Book Ratio 2.31
Return on Assets (%) -12.28
Return on Capital (%) -18.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.96
Total Assets 790.28
Total Liabilities 790.28
Total Equity 508.16
Share Outstanding 61250750
Price to Book Ratio 2.23
Return on Assets (%) -1.82
Return on Capital (%) -2.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 60.60
Total Assets 1138.48
Total Liabilities 1138.48
Total Equity 892.73
Share Outstanding 61250750
Price to Book Ratio 0.80
Return on Assets (%) -13.44
Return on Capital (%) -16
Particulars MAR 2024 (Values in Cr)
Net Income 1.47
Cash from Operations 2.40
Cash from Investing 10.22
Cash from Financing -2.80
Net change in Cash 7.31
Free Cash Flow 80.12
Particulars MAR 2023 (Values in Cr)
Net Income 12.80
Cash from Operations -419.97
Cash from Investing 430.33
Cash from Financing -18.37
Net change in Cash -10.49
Free Cash Flow -379.02
Particulars MAR 2022 (Values in Cr)
Net Income 1449.35
Cash from Operations 295.25
Cash from Investing 1282.57
Cash from Financing -1175.85
Net change in Cash -1.72
Free Cash Flow 307.76
Particulars MAR 2021 (Values in Cr)
Net Income -145.03
Cash from Operations 107.75
Cash from Investing -47.67
Cash from Financing -47.11
Net change in Cash 11.97
Free Cash Flow 129.52
Particulars MAR 2020 (Values in Cr)
Net Income -177.34
Cash from Operations -21.79
Cash from Investing -34.76
Cash from Financing 90.73
Net change in Cash 25.50
Free Cash Flow -14.88
Particulars MAR 2024 (Values in Cr)
Net Income 4.20
Cash from Operations 39.15
Cash from Investing -51.00
Cash from Financing 12.81
Net change in Cash -0.91
Free Cash Flow 114.18
Particulars MAR 2023 (Values in Cr)
Net Income -62.75
Cash from Operations -9.65
Cash from Investing 2.41
Cash from Financing 9.00
Net change in Cash 0.67
Free Cash Flow 28.72
Particulars MAR 2022 (Values in Cr)
Net Income -93.57
Cash from Operations -51.86
Cash from Investing 39.54
Cash from Financing 9.82
Net change in Cash -3.32
Free Cash Flow -43.81
Particulars MAR 2021 (Values in Cr)
Net Income -12.88
Cash from Operations 39.24
Cash from Investing -37.32
Cash from Financing -7.20
Net change in Cash -6.25
Free Cash Flow 53.78
Particulars MAR 2020 (Values in Cr)
Net Income -135.97
Cash from Operations -74.95
Cash from Investing -18.51
Cash from Financing 109.39
Net change in Cash 8.02
Free Cash Flow -72.63
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 460.80
  • 26 Days 427.20
  • 10 Days 457.00
  • 50 Days 388.30
  • 12 Days 451.50
  • 100 Days 317.70
  • 20 Days 431.50
  • 200 Days 171.70
470.15
PIVOT
First Resistance 484.30
Second Resistance 503.15
Third Resistance 517.30
First Support 451.30
Second Support 437.15
Third Support 418.30
RSI 67.47
MACD 24.26
Commodity Channel Index (CCI) 90.14
ADX 36.86
Williams % R -27.61

Over 1 Month

down

37.12

Over 3 Months

down

46.96

Over 6 Months

down

250.04

Over 1 Year

down

180.43

Over 3 Years

down

33.24

Over 5 Years

down

34.95

PANACEA BIOTEC LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PANACEA BIOTEC LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
25.59
Promoter Holdings
72.86
FII
0.36
DII
1.16
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dr. Rajesh Jain Shareholding of Promoter and Promoter Group 3.0217312E7 49.33
Mr. Sandeep Jain Shareholding of Promoter and Promoter Group 9590166.0 15.66
Mrs. Nirmala Jain Shareholding of Promoter and Promoter Group 2511000.0 4.1
First Lucre Partnership Co. Shareholding of Promoter and Promoter Group 2255815.0 3.68
Magic Square Hospitality Services Llp Public Shareholding 1641672.0 2.68
Second Lucre Partnership Co. Shareholding of Promoter and Promoter Group 57639.0 0.09
Mr. Ashish Jain Shareholding of Promoter and Promoter Group 500.0 0.0
Mr. Abhey Kumar Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Sandeep Jain (huf) (karta : Sandeep Jain) Shareholding of Promoter and Promoter Group 0.0 0.0
Rajesh Jain (huf) (karta : Rajesh Jain) Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Priyanka Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Harshet Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Ankesh Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Radhika Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Sumit Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Pamilla Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Meena Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Sunanda Jain Shareholding of Promoter and Promoter Group 0.0 0.0

PANACEA BIOTEC LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2011-09-19 0.75 Final 2011-09-21 Equity shares 2010-09-16 0.25 Final 2010-09-20 Equity shares 2008-09-19 1.0 Final 2008-09-23 Equity shares 2007-09-21 1.0 Final 2007-09-25 Equity shares 2005-08-12 0.0 Final 2005-08-17 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2003-02-03 10.0 1.0 2003-02-11

Learn More About Stocks

About PANACEA BIOTEC LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PANACEA BIOTEC LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Panacea Biotec Ltd?

Answer Field

The share price of Panacea Biotec Ltd for NSE is ₹ 471 and for BSE is ₹ 470.

What is the Market Cap of Panacea Biotec Ltd?

Answer Field

The market cap of Panacea Biotec Ltd for NSE is ₹ 28,84.91 Cr. and for BSE is ₹ 28,78.78 Cr. as of now.

What is the 52 Week High and Low of Panacea Biotec Ltd?

Answer Field

The 52 Week High and Low of Panacea Biotec Ltd for NSE is ₹ 489.00 and ₹ 112.35 and for BSE is ₹ 489.00 and ₹ 112.70.

How to Buy Panacea Biotec Ltd share?

Answer Field

You can trade in Panacea Biotec Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Panacea Biotec Ltd?

Answer Field

The 1 year returns on the stock has been 180.43%.

What is the Current Share Price of Panacea Biotec Ltd?

Answer Field

Panacea Biotec Ltd share price is for NSE ₹ 471 & for BSE ₹ 470 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Panacea Biotec Ltd Share?

Answer Field

The market cap of Panacea Biotec Ltd for NSE ₹ 28,84.91 & for BSE ₹ 28,78.78 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Panacea Biotec Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Panacea Biotec Ltd share is -212.63.

What is the PB ratio of Panacea Biotec Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Panacea Biotec Ltd share is 51.69.

How to Buy Panacea Biotec Ltd Share?

Answer Field

You can trade in Panacea Biotec Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Panacea Biotec Ltd Share on Bajaj Broking App?

Answer Field

To buy Panacea Biotec Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Panacea Biotec Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader